Bausch+Lomb Results Presentation Deck

MIEBO TM: Approved and Launching Soon¹ NDC 24208-377-05 Miebo perfluorohexyloctane ophthalmic solution Rx only Sterile 3 mL D NDC 24208-377-05 BAUSCH + LOMB Miebo: (perfluorohexyloctane ophthalmic solution) For Topical Ophthalmic Use Multiple-dose container STERILE Rx only 3 mL U.S. launch expected: 3023 1. See Slide 1 for further information on forward-looking information. 2. Key opinion leaders. CRITICAL SUCCESS FACTORS Grow the market by educating HCPs on disease etiology and difference between treatment modalities Establish MIEBO TM as the first and only therapeutic to address evaporative dry eye Provide broad and reliable access, reimbursement and affordability for patients Ensure best-in-class field force effectiveness Engage KOLs² within Ophthalmology and Optometry Expand on scientific evidence to strengthen differentiation Ensure timely and reliable supply 15

View entire presentation